Your browser doesn't support javascript.
loading
Gut microbiota and risk of coronary heart disease: a two-sample Mendelian randomization study.
Hu, Xiang-Zhi; Fu, Ling-Ling; Ye, Bin; Ao, Man; Yan, Ming; Feng, Hong-Chao.
Afiliação
  • Hu XZ; Medical College, Guizhou University, Guiyang, China.
  • Fu LL; Department of Oral and Maxillofacial Surgery, Guiyang Hospital of Stomatology, Guiyang, China.
  • Ye B; Department of Oral and Maxillofacial Surgery, Guiyang Hospital of Stomatology, Guiyang, China.
  • Ao M; Department of Oral and Maxillofacial Surgery, Guiyang Hospital of Stomatology, Guiyang, China.
  • Yan M; Department of Oral and Maxillofacial Surgery, Guiyang Hospital of Stomatology, Guiyang, China.
  • Feng HC; Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Front Cardiovasc Med ; 11: 1273666, 2024.
Article em En | MEDLINE | ID: mdl-38590695
ABSTRACT

Background:

The relationship between gut microbiota composition and coronary heart disease (CHD) has been recently reported in several observational studies. However, the causal effect of gut microbiota on coronary heart disease is uncharted.

Objective:

This study attempted to investigate the effect of gut microbiota on coronary heart disease by Mendelian randomization (MR) analysis.

Methods:

Through the two-sample MR method, single-nucleotide polymorphisms relevant to gut microbiota were selected as instrument variables to evaluate the causal association between gut microbiota and the risk of CHD.

Results:

According to the selection criteria of the inverse variance-weighted average method, Class Actinobacteria, Class Lentisphaeria, Family Clostridiales vadinBB60group, Genus Clostridium innocuum group, Genus Bifidobacterium, Genus Butyricicoccus, Genus Oxalobacter, Genus Turicibacter, and Order Victivallales, presented a suggestive association with coronary heart disease.

Conclusion:

This two-sample Mendelian randomization study found that gut microbiota was causally associated with coronary heart disease. Further randomized controlled trials are needed to clarify the protective effect of probiotics on coronary heart disease and their specific protective mechanisms.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Cardiovasc Med Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Cardiovasc Med Ano de publicação: 2024 Tipo de documento: Article